Pages that link to "Q46837798"
Jump to navigation
Jump to search
The following pages link to NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity (Q46837798):
Displaying 50 items.
- NADPH oxidases in heart failure: poachers or gamekeepers? (Q27001094) (← links)
- Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine (Q27692687) (← links)
- Cardio-Oncology: A Focused Review of Anthracycline-, Human Epidermal Growth Factor Receptor 2 Inhibitor-, and Radiation-Induced Cardiotoxicity and Management (Q28068290) (← links)
- Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application (Q28468693) (← links)
- Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition (Q28475976) (← links)
- Autophagy inhibition enhances daunorubicin-induced apoptosis in K562 cells (Q28478256) (← links)
- Non-invasive imaging and monitoring cardiotoxicity of cancer therapeutic drugs (Q30427656) (← links)
- Mechanisms of Anthracycline Cardiotoxicity and Strategies to Decrease Cardiac Damage (Q30439608) (← links)
- Polymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia (Q33395469) (← links)
- Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy (Q33441706) (← links)
- Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials (Q33619867) (← links)
- Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis. (Q33671281) (← links)
- Long-term consequences of hematopoietic stem cell transplantation: current state of the science (Q33705877) (← links)
- Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma (Q34062500) (← links)
- Urinary coproporphyrin I/(I + III) ratio as a surrogate for MRP2 or other transporter activities involved in methotrexate clearance (Q34065294) (← links)
- Limitations in Adjuvant Breast Cancer Therapy: The Predictive Potential of Pharmacogenetics and Pharmacogenomics. (Q34095952) (← links)
- Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy (Q34322162) (← links)
- Multidrug resistance protein 1 (MRP1, ABCC1), a "multitasking" ATP-binding cassette (ABC) transporter (Q34467407) (← links)
- Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment (Q34639876) (← links)
- Repositioning of Tyrosine Kinase Inhibitors as Antagonists of ATP-Binding Cassette Transporters in Anticancer Drug Resistance (Q34774854) (← links)
- Urinary elimination of coproporphyrins is dependent on ABCC2 polymorphisms and represents a potential biomarker of MRP2 activity in humans (Q34897941) (← links)
- Plasma high sensitivity troponin T levels in adult survivors of childhood leukaemias: determinants and associations with cardiac function (Q35034995) (← links)
- Doxorubicin pathways: pharmacodynamics and adverse effects (Q35048393) (← links)
- Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group. (Q35086334) (← links)
- Multivariable regression analysis of febrile neutropenia occurrence in early breast cancer patients receiving chemotherapy assessing patient-related, chemotherapy-related and genetic risk factors (Q35123683) (← links)
- Chemotherapy-induced weakness and fatigue in skeletal muscle: the role of oxidative stress (Q35222202) (← links)
- Role of genetic susceptibility in development of treatment-related adverse outcomes in cancer survivors (Q35327266) (← links)
- National Cancer Institute-National Heart, Lung and Blood Institute/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage a (Q35549037) (← links)
- Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model (Q35775234) (← links)
- The G671V variant of MRP1/ABCC1 links doxorubicin-induced acute cardiac toxicity to disposition of the glutathione conjugate of 4-hydroxy-2-trans-nonenal (Q35840905) (← links)
- Interindividual variability in hepatic expression of the multidrug resistance-associated protein 2 (MRP2/ABCC2): quantification by liquid chromatography/tandem mass spectrometry (Q35913104) (← links)
- A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancer (Q36004460) (← links)
- Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide (Q36054324) (← links)
- Loss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice (Q36186168) (← links)
- Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice (Q36186203) (← links)
- Higher frequency of genetic variants conferring increased risk for ADRs for commonly used drugs treating cancer, AIDS and tuberculosis in persons of African descent (Q36384257) (← links)
- Individual responses to chemotherapy-induced oxidative stress (Q36406442) (← links)
- Pharmacogenomics of drug metabolizing enzymes and transporters: implications for cancer therapy (Q36441493) (← links)
- Oxidative stress, redox signaling, and metal chelation in anthracycline cardiotoxicity and pharmacological cardioprotection. (Q36568908) (← links)
- Pharmacogenomics as a risk mitigation strategy for chemotherapeutic cardiotoxicity (Q36637796) (← links)
- Genomic profiling reveals the potential role of TCL1A and MDR1 deficiency in chemotherapy-induced cardiotoxicity (Q36800903) (← links)
- Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms (Q36804526) (← links)
- Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. (Q36887091) (← links)
- Risk factors for anthracycline-associated cardiotoxicity (Q36921775) (← links)
- Cardiac side effects of anticancer treatments: new mechanistic insights (Q36957758) (← links)
- Loss of Mrp1 Potentiates Doxorubicin-Induced Cytotoxicity in Neonatal Mouse Cardiomyocytes and Cardiac Fibroblasts (Q37023604) (← links)
- Clinical and Genetic Determinants of Cardiomyopathy Risk among Hematopoietic Cell Transplantation Survivors (Q37159230) (← links)
- Genetic determinants of drug response in heart failure (Q37167800) (← links)
- NOX enzymes as novel targets for drug development (Q37176104) (← links)
- Genetic susceptibility to anthracycline-related congestive heart failure in survivors of haematopoietic cell transplantation (Q37227651) (← links)